BlackRock Group’s ChemoCentryx, Inc. CCXI Stock Holding History

BlackRock Group’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,920	Closed	-$11K	–	2806
2013 Q3	$11K	Buy	+1,920	New	+$20.8K	﹤0.01%	2833

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group's CCXI Position: Q4 2013 in Review

BlackRock Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2013, closing a stake of 1,920 shares — an estimated $11K sold.

BlackRock Group first reported a position in CCXI in Q3 2013 and held it in 1 quarter. The position peaked at $11K in Q3 2013. 60 funds tracked by Wall St. Rank hold CCXI as of Q4 2013.

BlackRock Group reported no remaining ChemoCentryx, Inc. position as of Q4 2013 after selling out during the quarter.
BlackRock Group sold 1,920 ChemoCentryx, Inc. shares in Q4 2013, an estimated $11K.
BlackRock Group first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 1 quarter.
BlackRock Group's ChemoCentryx, Inc. position peaked at $11K in Q3 2013.
60 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.